Competitive Analysis of Softgel Capsules Market

Key Players

Competitive Landscape

Formulation support, regulatory approvals, shell options and price shape buyer preference for a softgel supplier, and a qualified supplier usually keeps a product for many years. Pharma buyers weigh audit history and stability data most heavily.

Companies at the top of the softgel capsules market split between global contract groups with pharma approvals, supplement specialists with high-volume lines, and regional producers with low costs. Price pressure is strongest in commodity fish oil and vitamin softgels, and margins hold better in pharma and plant-based products.

Company developments mapped to drivers, trends and opportunities (2026-2036)

Development Driver Trend Opportunity
March 2026: Lonza agrees to divest Capsules & Health Ingredients. Investor interest in dosage forms. Capsule asset consolidation. Capacity investment by new owners.
April 2026: Roquette presents plant-based softgel premixes. Vegetarian supplement demand. Plant-based shells. Vegan and halal softgels.
August 2026: GELITA moves to near-full ownership of SelJel. Gelatin supply security. Gelatin consolidation. Secure shell supply contracts.

Lonza, Roquette and GELITA are concentrating shell supply and widening plant-based options, so encapsulators with secure gelatin contracts and vegetarian capability will win more brand launches through 2036.

Who leads the softgel capsules market?

Catalent and Thermo Fisher Scientific (Patheon) hold the strongest positions in pharma softgels, and Sirio Pharma and Aenova hold large positions in supplement and European contract manufacturing.

Which companies have documented positions?

Catalent, Thermo Fisher Scientific (Patheon), Aenova and Procaps hold clear pharma positions, Sirio Pharma and Captek hold clear supplement positions, and Fuji Capsule holds a strong position in Japan.

What should buyers evaluate before approving a supplier?

Regulatory approvals and audit history come first in supplier checks, followed by shell material options, fill compatibility, stability data and capacity. Supplement brands also review minimum order sizes and lead times.

How is competition expected to change through 2036?

Global groups will expand plant-based and specialty fill capacity, and regional producers will compete on cost in commodity supplements, as brands split volumes across several suppliers.

Representative Company Overview

Company Positioning Recent development
Catalent Global contract developer with large softgel capacity Broad gelatin and plant-based softgel technologies.
Sirio Pharma Supplement-focused encapsulator in China Fish oil and vitamin softgels for global brands.
Procaps Group (Softigel) Pharma softgel developer in Latin America Softigel contract development services.

Research Methodology

The companies included in the report represent current market structure and do not indicate a market-share ranking. Company positions reflect product range, channel reach and recent activity.

Future Market Insights

Softgel Capsules Market